{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38144071", "DateRevised": {"Year": "2023", "Month": "12", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.3c05719"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "8", "Issue": "50", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "19"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Development of a New Class of Monoamine Oxidase-B Inhibitors by Fine-Tuning the Halogens on the Acylhydrazones.", "Pagination": {"StartPage": "47606", "EndPage": "47615", "MedlinePgn": "47606-47615"}, "Abstract": {"AbstractText": ["A total of 14 acyl hydrazine derivatives (<b>ACH1-ACH14</b>) were developed and examined for their ability to block monoamine oxidase (MAO). Thirteen analogues showed stronger inhibition potency against MAO-B than MAO-A. With a half-maximum inhibitory concentration of 0.14 \u03bcM, <b>ACH10</b> demonstrated the strongest inhibitory activity against MAO-B, followed by <b>ACH14</b>, <b>ACH13</b>, <b>ACH8</b>, and <b>ACH3</b> (IC<sub>50</sub> = 0.15, 0.18, 0.20, and 0.22 \u03bcM, respectively). Structure-activity relationships suggested that the inhibition effect on MAO-B resulted from the combination of halogen substituents of the A- and/or B-rings. This series concluded that when -F was substituted to the B-ring, MAO-B inhibitory activities were high, except for <b>ACH6</b>. In the inhibition kinetics study, the compounds <b>ACH10</b> and <b>ACH14</b> were identified as competitive inhibitors, with <i>K<sub>i</sub></i> values of 0.097 \u00b1 0.0021 and 0.10 \u00b1 0.038 \u03bcM, respectively. In a reversibility experiment using the dialysis methods, <b>ACH10</b> and <b>ACH14</b> showed effective recoveries of MAO-B inhibition as much as lazabemide, a reversible reference. These experiments proposed that <b>ACH10</b> and <b>ACH14</b> were efficient, reversible competitive MAO-B inhibitors. In addition, the lead molecules showed good blood-brain barrier permeation with the PAMPA method. The molecular docking and molecular dynamics simulation study confirmed that the hit compound ACH10 can form a stable protein-ligand complex by forming a hydrogen bond with the NH atom in the hydrazide group of the compound."], "CopyrightInformation": "\u00a9 2023 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Jayan", "ForeName": "Jayalakshmi", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea."}], "LastName": "Lee", "ForeName": "Jiseong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Kumar", "ForeName": "Sunil", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Manoharan", "ForeName": "Amritha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Narayanan", "ForeName": "Anishma Payyappilliparambil", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Graphic Era Hill University, Dehradun 248002, Uttarakhand, India."}], "LastName": "Jauhari", "ForeName": "Reenoo", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62514, Egypt."}], "LastName": "Abdelgawad", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Ebrahim", "ForeName": "Hasnaa Ali", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Mary Zachariah", "ForeName": "Subin", "Initials": "S"}, {"Identifier": ["0000-0002-7203-3712"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea."}], "LastName": "Kim", "ForeName": "Hoon", "Initials": "H"}, {"Identifier": ["0000-0002-6658-4497"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India."}], "LastName": "Mathew", "ForeName": "Bijo", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rojas R. J.; Edmondson D. E.; Almos T.; Scott R.; Massari M. E. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques. Bioorg. Med. Chem. 2015, 23, 770\u2013778. 10.1016/j.bmc.2014.12.063.", "ArticleIdList": ["10.1016/j.bmc.2014.12.063", "25600407"]}, {"Citation": "Behl T.; Kaur D.; Sehgal A.; Singh S.; Sharma N.; Zengin G.; Andronie-Cioara F. L.; Toma M. M.; Bungau S.; Bumbu A. G. Role of monoamine oxidase activity in Alzheimer\u2019s disease: An insight into the therapeutic potential of inhibitors. Molecules 2021, 26, 372410.3390/molecules26123724.", "ArticleIdList": ["10.3390/molecules26123724", "PMC8234097", "34207264"]}, {"Citation": "Robinson S. J.; Petzer J. P.; Petzer A.; Bergh J. J.; Lourens A. C. U. Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg. Med. Chem. Lett. 2013, 23, 4985\u20134989. 10.1016/j.bmcl.2013.06.050.", "ArticleIdList": ["10.1016/j.bmcl.2013.06.050", "23860591"]}, {"Citation": "Guglielmi P.; Mathew B.; Secci D.; Carradori S. Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors. Eur. J. Med. Chem. 2020, 205, 11265010.1016/j.ejmech.2020.112650.", "ArticleIdList": ["10.1016/j.ejmech.2020.112650", "32920430"]}, {"Citation": "Dugger B. N.; Dickson D. W. Pathology of neurodegenerative diseases. Cold Spring Harbor Perspect. Biol. 2017, 9, a02803510.1101/cshperspect.a028035.", "ArticleIdList": ["10.1101/cshperspect.a028035", "PMC5495060", "28062563"]}, {"Citation": "Soria Lopez J. A.; Gonz\u00e1lez H. M.; L\u00e9ger G. C.. Alzheimer\u2019s Disease. In Handbook of Clinical Neurology; Elsevier, 2019; pp 231\u2013255.", "ArticleIdList": ["31753135"]}, {"Citation": "Ramsay R. R. Monoamine oxidases: The biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr. Top. Med. Chem. 2012, 12, 2189\u20132209. 10.2174/156802612805219978.", "ArticleIdList": ["10.2174/156802612805219978", "23231396"]}, {"Citation": "Youdim M. B. H.; Bakhle Y. S. Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br. J. Pharmacol. 2006, 147, S287\u2013S296. 10.1038/sj.bjp.0706464.", "ArticleIdList": ["10.1038/sj.bjp.0706464", "PMC1760741", "16402116"]}, {"Citation": "Saura J.; Luque J. M.; Cesura A. M.; Prada M. D.; Chan-Palay V.; Huber G.; L\u00f6ffler J.; Richards J. G. Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994, 62, 15\u201330. 10.1016/0306-4522(94)90311-5.", "ArticleIdList": ["10.1016/0306-4522(94)90311-5", "7816197"]}, {"Citation": "Imbimbo B. P.; Watling M. Investigational BACE inhibitors for the treatment of Alzheimer\u2019s disease. Expert Opin. Invest. Drugs 2019, 28, 967\u2013975. 10.1080/13543784.2019.1683160.", "ArticleIdList": ["10.1080/13543784.2019.1683160", "31661331"]}, {"Citation": "Tipton K. F. 90 years of monoamine oxidase: some progress and some confusion. J. Neural Transm. 2018, 125, 1519\u20131551. 10.1007/s00702-018-1881-5.", "ArticleIdList": ["10.1007/s00702-018-1881-5", "29637260"]}, {"Citation": "Lum C. T.; Stahl S. M. Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression. CNS Spectr. 2012, 17, 107\u2013120. 10.1017/S1092852912000594.", "ArticleIdList": ["10.1017/S1092852912000594", "23888494"]}, {"Citation": "Elshaflu H.; Todorovi\u0107 T. R.; Nikoli\u0107 M.; Loli\u0107 A.; Vi\u0161njevac A.; Hagenow S.; Padr\u00f3n J. M.; Garc\u00eda-Sosa A. T.; Djordjevi\u0107 I. S.; Grubi\u0161i\u0107 S.; Stark H.; Filipovi\u0107 N. R. Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: Experimental and in-silico studies. Front. Chem. 2018, 6, 24710.3389/fchem.2018.00247.", "ArticleIdList": ["10.3389/fchem.2018.00247", "PMC6037691", "30018949"]}, {"Citation": "Moussa-Pacha N. M.; Abdin S. M.; Omar H. A.; Alniss H.; Al-Tel T. H. BACE1 inhibitors: Current status and future directions in treating Alzheimer\u2019s disease. Med. Res. Rev. 2020, 40, 339\u2013384. 10.1002/med.21622.", "ArticleIdList": ["10.1002/med.21622", "31347728"]}, {"Citation": "Mathew B.; U\u00e7ar G.; Mathew G. E.; Mathew S.; Purapurath P. K.; Moolayil F.; Mohan S.; Gupta S. V. Monoamine oxidase inhibitory activity: Methyl-versus chlorochalcone derivatives. ChemMedChem 2016, 11, 2649\u20132655. 10.1002/cmdc.201600497.", "ArticleIdList": ["10.1002/cmdc.201600497", "27902880"]}, {"Citation": "Mathew B.; Ucar G.; Yabanogclu-Ciftci S.; Baysal I.; Suresh J. A.; Mathew G. E.; Vilapurathu J. K.; Nadeena A. M.; Nabeela P.; Lakshmi V.; Haridas A.; Fathima F. Development of fluorinated thienylchalcones as monoamine oxidase-B inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Lett. Org. Chem. 2015, 12, 605\u2013613. 10.2174/1570178612666150903213416.", "ArticleIdList": ["10.2174/1570178612666150903213416"]}, {"Citation": "Iacovino L. G.; Pinzi L.; Facchetti G.; Bortolini B.; Christodoulou M. S.; Binda C.; Rastelli G.; Rimoldi I.; Passarella D.; Paolo M. L. D.; Via L. D. Promising non-cytotoxic monosubstituted chalcones to target monoamine oxidase-B. ACS Med. Chem. Lett. 2021, 12, 1151\u20131158. 10.1021/acsmedchemlett.1c00238.", "ArticleIdList": ["10.1021/acsmedchemlett.1c00238", "PMC8274062", "34262643"]}, {"Citation": "Mellado M.; Salas C. O.; Uriarte E.; Vi\u00f1a D.; Jara-Guti\u00e9rrez C.; Matos M. J.; Cuellar M. Design, synthesis and docking calculations of prenylated chalcones as selective monoamine oxidase B inhibitors with antioxidant activity. ChemistrySelect 2019, 4, 7698\u20137703. 10.1002/slct.201901282.", "ArticleIdList": ["10.1002/slct.201901282"]}, {"Citation": "Koyiparambath V. P.; Rajappan K. P.; Rangarajan T. M.; Al-Sehemi A. G.; Pannipara M.; Bhaskar V.; Nair A. S.; Sudevan S. T.; Kumar S.; Mathew B. Deciphering the detailed structure\u2013activity relationship of coumarins as monoamine oxidase enzyme inhibitors\u2014An updated review. Chem. Biol. Drug Des. 2021, 98, 655\u2013673. 10.1111/cbdd.13919.", "ArticleIdList": ["10.1111/cbdd.13919", "34233082"]}, {"Citation": "Kumar S.; Nair A. S.; Abdelgawad M. A.; Mathew B. Exploration of the detailed structure\u2013activity relationships of isatin and their isomers as monoamine oxidase inhibitors. ACS Omega 2022, 7, 16244\u201316259. 10.1021/acsomega.2c01470.", "ArticleIdList": ["10.1021/acsomega.2c01470", "PMC9118264", "35601305"]}, {"Citation": "Kr\u00f3licka E.; Kie\u0107-Kononowicz K.; \u0141a\u017cewska D. Chalcones as potential ligands for the treatment of Parkinson\u2019s disease. Pharmaceuticals 2022, 15, 84710.3390/ph15070847.", "ArticleIdList": ["10.3390/ph15070847", "PMC9317344", "35890146"]}, {"Citation": "Tripathi R. K. P.; Ayyannan S. R. Design, synthesis, and evaluation of 2-amino-6-nitrobenzothiazole-derived hydrazones as MAO inhibitors: Role of the methylene spacer group. ChemMedChem 2016, 11, 1551\u20131567. 10.1002/cmdc.201600202.", "ArticleIdList": ["10.1002/cmdc.201600202", "27332045"]}, {"Citation": "Tok F.; Sa\u011fl\u0131k B. N.; \u00d6zkay Y.; Ilg\u0131n S.; Kaplanc\u0131kl\u0131 Z. A.; Ko\u00e7yi\u011fit-Kaymak\u00e7\u0131o\u011flu B. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity. Bioorg. Chem. 2021, 114, 10503810.1016/j.bioorg.2021.105038.", "ArticleIdList": ["10.1016/j.bioorg.2021.105038", "34102520"]}, {"Citation": "Salgin-Goksen U.; Telli G.; Erikci A.; Dedecengiz E.; Tel B. C.; Kaynak F. B.; Yelekci K.; Ucar G.; Gokhan-Kelekci N. New 2-pyrazoline and hydrazone derivatives as potent and selective monoamine oxidase A inhibitors. J. Med. Chem. 2021, 64, 1989\u20132009. 10.1021/acs.jmedchem.0c01504.", "ArticleIdList": ["10.1021/acs.jmedchem.0c01504", "33533632"]}, {"Citation": "Bolognino I.; Giangregorio N.; Tonazzi A.; Mart\u00ednez A. L.; Altomare C. D.; Loza M. I.; Sablone S.; Cellamare S.; Catto M. Synthesis and biological evaluation of dantrolene-like hydrazide and hydrazone analogues as multitarget agents for neurodegenerative diseases. ChemMedChem 2021, 16, 2807\u20132816. 10.1002/cmdc.202100209.", "ArticleIdList": ["10.1002/cmdc.202100209", "PMC8518391", "34047061"]}, {"Citation": "de Freitas Silva M.; Lima E. T.; Pruccoli L.; Castro N.; Guimar\u00e3es M.; da Silva F.; Nadur N. F.; de Azevedo L.; K\u00fcmmerle A.; Guedes I.; Dardenne L.; Gontijo V.; Tarozzi A.; Viegas C. Design, synthesis and biological evaluation of novel triazole N-acylhydrazone hybrids for Alzheimer\u2019s disease. Molecules 2020, 25, 316510.3390/molecules25143165.", "ArticleIdList": ["10.3390/molecules25143165", "PMC7397262", "32664425"]}, {"Citation": "D\u00e9zsi L.; V\u00e9csei L. Safinamide for the treatment of Parkinson\u2019s disease. Expert Opin. Invest. Drugs 2014, 23, 729\u2013742. 10.1517/13543784.2014.897694.", "ArticleIdList": ["10.1517/13543784.2014.897694", "24650154"]}, {"Citation": "Mathew B.; Carradori S.; Guglielmi P.; Uddin M. S.; Kim H. New aspects of monoamine oxidase B inhibitors: The key role of halogens to open the golden door. Curr. Med. Chem. 2020, 28, 266\u2013283. 10.2174/0929867327666200121165931.", "ArticleIdList": ["10.2174/0929867327666200121165931", "31965939"]}, {"Citation": "Abid S. M. A.; Younus H. A.; Al-Rashida M.; Arshad Z.; Maryum T.; Gilani M. A.; Alharthi A. I.; Iqbal J. Sulfonyl hydrazones derived from 3-formylchromone as non-selective inhibitors of MAO-A and MAO-B: Synthesis, molecular modelling and in-silico ADME evaluation. Bioorg. Chem. 2017, 75, 291\u2013302. 10.1016/j.bioorg.2017.10.001.", "ArticleIdList": ["10.1016/j.bioorg.2017.10.001", "29065322"]}, {"Citation": "Oh J. M.; Rangarajan T. M.; Chaudhary R.; Singh R. P.; Singh M.; Singh R. P.; Tondo A. R.; Gambacorta N.; Nicolotti O.; Mathew B.; Kim H. Novel class of chalcone oxime ethers as potent monoamine oxidase-B and acetylcholinesterase inhibitors. Molecules 2020, 25, 235610.3390/molecules25102356.", "ArticleIdList": ["10.3390/molecules25102356", "PMC7288026", "32443652"]}, {"Citation": "Taghavi A.; Nasir S.; Pickhardt M.; Heyny-von Haussen R.; Mall G.; Mandelkow E.; Mandelkow E. M.; Schmidt B. N\u2019-benzylidene-benzohydrazides as novel and selective tau-PHF ligands. J Alzheimers Dis. 2011, 27 (4), 835\u2013843. 10.3233/JAD-2011-111238.", "ArticleIdList": ["10.3233/JAD-2011-111238", "21891864"]}, {"Citation": "Arya N.; Mishra S. K.; Suryaprakash N. Intramolecular hydrogen bond directed distribution of conformational populations in the derivatives of N\u2032-benzylidenebenzohydrazide. New J. Chem. 2019, 43 (33), 13134\u201313142. 10.1039/C9NJ03071A.", "ArticleIdList": ["10.1039/C9NJ03071A"]}, {"Citation": "Lee H. W.; Ryu H. W.; Kang M. -G.; Park D.; Lee H.; Shin H. M.; Oh S. -R.; Kim H. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi. Int. J. Biol. Macromol. 2017, 97, 598\u2013605. 10.1016/j.ijbiomac.2017.01.080.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.01.080", "28109809"]}, {"Citation": "Oh J. M.; Kang Y.; Hwang J. H.; Park J. -H.; Shin W. -H.; Mun S. -K.; Lee J. U.; Yee S. -T.; Kim H. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B. Int. J. Biol. Macromol. 2022, 217, 910\u2013921. 10.1016/j.ijbiomac.2022.07.178.", "ArticleIdList": ["10.1016/j.ijbiomac.2022.07.178", "35908673"]}, {"Citation": "Baek S. C.; Park M. H.; Ryu H. W.; Lee J. P.; Kang M. -G.; Park D.; Park C. M.; Oh S. -R.; Kim H. Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A. Bioorg. Chem. 2019, 83, 317\u2013325. 10.1016/j.bioorg.2018.10.051.", "ArticleIdList": ["10.1016/j.bioorg.2018.10.051", "30396116"]}, {"Citation": "Baek S. C.; Lee H. W.; Ryu H. W.; Kang M. -G.; Park D.; Kim S. H.; Cho M. -L.; Oh S. -R.; Kim H. Selective inhibition of monoamine oxidase A by hispidol. Bioorg. Med. Chem. Lett. 2018, 28, 584\u2013588. 10.1016/j.bmcl.2018.01.049.", "ArticleIdList": ["10.1016/j.bmcl.2018.01.049", "29395970"]}, {"Citation": "Oh J. M.; Jang H. -J.; Kim W. J.; Kang M. -G.; Baek S. C.; Lee J. P.; Park D.; Oh S. -R.; Kim H. Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B. Int. J. Biol. Macromol. 2020, 151, 441\u2013448. 10.1016/j.ijbiomac.2020.02.144.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.02.144", "32087226"]}, {"Citation": "Lee H. W.; Ryu H. W.; Kang M. -G.; Park D.; Oh S. -R.; Kim H. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg. Med. Chem. Lett. 2016, 26, 4714\u20134719. 10.1016/j.bmcl.2016.08.044.", "ArticleIdList": ["10.1016/j.bmcl.2016.08.044", "27575476"]}, {"Citation": "Mathew B.; Haridas A.; U\u00e7ar G.; Baysal I.; Joy M.; Mathew G. E.; Lakshmanan B.; Jayaprakash V. Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO-B inhibitors. ChemMedChem 2016, 11, 1161\u20131171. 10.1002/cmdc.201600122.", "ArticleIdList": ["10.1002/cmdc.201600122", "27159243"]}, {"Citation": "Parambi D. G. T.; Oh J. M.; Baek S. C.; Lee J. P.; Tondo A. R.; Nicolotti O.; Kim H.; Mathew B. Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorg. Chem. 2019, 93, 10333510.1016/j.bioorg.2019.103335.", "ArticleIdList": ["10.1016/j.bioorg.2019.103335", "31606547"]}, {"Citation": "Vishal V. P.; Oh J. M.; Khames A.; Abdelgawad M. A.; Nair A. S.; Nath L. R.; Gambacorta N.; Ciriaco F.; Nicolotti O.; Kim H.; Mathew B. Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders. Pharmaceutics 2021, 13, 85010.3390/pharmaceutics13060850.", "ArticleIdList": ["10.3390/pharmaceutics13060850", "PMC8226672", "34201128"]}, {"Citation": "Shaw Research D. E. . Schrodinger Release Desmond molecular dynamics system. Maestro Desmond Interoperability Tools, 2022."}, {"Citation": "Ayipo Y. O.; Alananzeh W. A.; Ahmad I.; Patel H.; Mordi M. N. Structural modelling and in silico pharmacology of \u03b2-carboline alkaloids as potent 5-HT1A receptor antagonists and reuptake inhibitors. J. Biomol. Struct. Dyn. 2023, 41, 6219\u20136235. 10.1080/07391102.2022.2104376.", "ArticleIdList": ["10.1080/07391102.2022.2104376", "35881145"]}, {"Citation": "Farhan M. M.; Guma M. A.; Rabeea M. A.; Ahmad I.; Patel H. Synthesizes, characterization, molecular docking and in vitro bioactivity study of new compounds containing triple beta lactam rings. J. Mol. Struct. 2022, 1269, 13378110.1016/j.molstruc.2022.133781.", "ArticleIdList": ["10.1016/j.molstruc.2022.133781"]}, {"Citation": "Radwan H. A.; Ahmad I.; Othman I. M. M.; Gad-Elkareem M. A. M.; Patel H.; Aouadi K.; Snoussi M.; Kadri A. Design, synthesis, in vitro anticancer and antimicrobial evaluation, SAR analysis, molecular docking and dynamic simulation of new pyrazoles, triazoles and pyridazines based isoxazole. J. Mol. Struct. 2022, 1264, 13331210.1016/j.molstruc.2022.133312.", "ArticleIdList": ["10.1016/j.molstruc.2022.133312"]}, {"Citation": "Finberg J. P. M.; Rabey J. M. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front. Pharmacol. 2016, 7, 34010.3389/fphar.2016.00340.", "ArticleIdList": ["10.3389/fphar.2016.00340", "PMC5067815", "27803666"]}, {"Citation": "Mostert S.; Petzer A.; Petzer J. P. Indanones as high-potency reversible inhibitors of monoamine oxidase. ChemMedChem 2015, 10 (5), 862\u2013873. 10.1002/cmdc.201500059.", "ArticleIdList": ["10.1002/cmdc.201500059", "25820651"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "4"}, {"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "11", "Day": "24"}, {"Year": "2023", "Month": "12", "Day": "25", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "25", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "12", "Day": "25", "Hour": "4", "Minute": "26"}, {"Year": "2023", "Month": "12", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["38144071", "PMC10733988", "10.1021/acsomega.3c05719"]}}], "PubmedBookArticle": []}